Somerdale Treatment Services — Suite 10 is a NJ DMHAS-licensed addiction treatment provider in Somerdale, Camden County. Per the 2024 SAMHSA National Directory, the facility offers intensive outpatient and medication-assisted treatment.
Accreditation / certification: CARF International and SAMHSA OTP certification.
At a glance
- Address: 1200 South White Horse Suite 10, Somerdale, NJ 08083
- County: Camden
- Phone: 856-679-2500
- Licensure: NJ DMHAS-licensed (state substance use treatment agency)
- Accreditation: CARF International and SAMHSA OTP certification
- Levels of care: Intensive outpatient (IOP), Outpatient, Outpatient MAT (methadone/buprenorphine/naltrexone), and Regular outpatient
- MAT medications offered: Buprenorphine, Methadone, and Naltrexone
- Populations served: Active duty military, Men, Women, Co-occurring mental health and SUD, Criminal justice-involved, Hiv Aids, Intimate Partner Violence Survivors, LGBTQ, Military families, Pregnant and postpartum women, Seniors, Sexual Abuse Survivors, Trauma Survivors, Veterans, and Young adults
- Payment accepted: Private insurance, NJ FamilyCare (Medicaid), Medicare, State-funded / SAMHSA block grant, and Self-pay / cash
Program overview
Per public records, Somerdale Treatment Services — Suite 10 provides intensive outpatient and medication-assisted treatment. The program operates from 1200 South White Horse Suite 10 and serves patients across Camden County and surrounding areas. Specific day-to-day program schedules, clinical staff composition, and admission capacity are not published in SAMHSA’s directory — these details should be confirmed directly with the facility during your intake call.
What Somerdale Treatment Services — Suite 10 is documented to offer
- Accreditation: Somerdale Treatment Services — Suite 10 holds CARF International and SAMHSA OTP certification. Accreditation is a voluntary external quality review — facilities with multiple accreditations have committed to ongoing clinical and operational standards verification.
- Medication-assisted treatment: the facility dispenses or prescribes Buprenorphine, Methadone, and Naltrexone for opioid use disorder. MAT is the most evidence-based pharmacotherapy for OUD.
- LGBTQ population served: the facility self-reports LGBTQ-affirming programming. Ask about specific staff training and clinical policies during intake to confirm the programming depth.
- Veteran programming: the facility is configured to serve veterans — confirm whether care is VA-direct, VA Community Care, TRICARE, or standalone commercial during intake.
- NJ FamilyCare accepted: important for Medicaid-covered patients. Verify which of the five current MCO networks the facility participates in before assuming in-network status.
- State-funded slots available: important for uninsured/underinsured NJ residents. Contact the DMHAS Access Center at 844-276-2777 for current availability.
Who Somerdale Treatment Services — Suite 10 is typically appropriate for
Based on the public data, Somerdale Treatment Services — Suite 10 is likely appropriate for patients with opioid use disorder seeking medication-assisted treatment in an outpatient setting and patients who need structured clinical support while maintaining work/family responsibilities (IOP).
This is a directional assessment from public records — it’s not a substitute for a clinical intake. The facility’s admissions team will assess fit during your initial call.
What to verify before calling Somerdale Treatment Services — Suite 10
- NJ DMHAS licensure — confirm current status via the NJ DMHAS licensure lookup.
- Insurance network status — call your insurance carrier and verify that Somerdale Treatment Services — Suite 10 is currently in-network for your specific plan. Self-reported payer acceptance in the SAMHSA directory is a starting point, not proof of current in-network contract.
- Current level of care availability — ask specifically about bed or slot availability at the level of care you need. SAMHSA-listed services do not guarantee current open admissions.
- Medications policy — if you’re on prescribed buprenorphine, methadone, or other psychiatric medication, confirm the facility’s policy on maintaining your medication during treatment.
- Length-of-stay expectations — ask what a typical length of stay looks like for patients with your clinical presentation.
- MAT specifics — which specific medication(s), induction/transition protocol, and continuation plan post-discharge.
- CARF accreditation — verify current status at carf.org.
Considering Somerdale Treatment Services — Suite 10?
Not sure if Somerdale Treatment Services — Suite 10 is the right fit? Call (888) 699-0742 to talk through your options. We’ll help you understand what to ask, what insurance considerations apply, and how it compares with other facilities in the area.
About this profile
Sources: SAMHSA 2024 National Directory of Drug and Alcohol Abuse Treatment Programs, NJ DMHAS licensure records.
Last verified: 2026-04-21
Found an error? Request a correction. We review every submission.
Inclusion is not endorsement. Appearance on this directory reflects publicly-available licensure and accreditation data. It does not imply the site recommends Somerdale Treatment Services — Suite 10 over any other facility.